Molecular and Biochemical Toxicology

Wiley (Verlag)
  • 5. Auflage
  • |
  • erschienen am 6. November 2017
  • |
  • 1040 Seiten
E-Book | ePUB mit Adobe DRM | Systemvoraussetzungen
978-1-119-04243-3 (ISBN)
Written as an advanced text for toxicology students, this book is much more than an introduction and provides in-depth information describing the underlying mechanisms through which toxicants produce their adverse responses.
* Links traditional toxicology to modern molecular techniques, important for teaching to graduate courses and professional studies
* Uses a didactic approach with basic biological or theoretical background for the methodology presented
* Brings together and comprehensively covers a range of dynamic aspects in biochemical and molecular toxicology
* Guides student and professional toxicologists in comprehending a broad range of issues, compiled and authored by a diverse group of experts
* "A good introductory textbook covering the biochemical toxicology of organic substances and the relevant methodology in some detail.... It offers good value for money and can be recommended as a textbook for appropriate courses" - BTS Newsletter review of the 4th edition
5. Auflage
  • Englisch
  • Newark
  • |
  • USA
John Wiley & Sons
  • 55,33 MB
978-1-119-04243-3 (9781119042433)
1119042437 (1119042437)
weitere Ausgaben werden ermittelt
ROBERT C. SMART, PhD, is a William Neal Reynolds Professor of Toxicology, the Director of the Center for Human Health and the Environment, and the former Director of the Toxicology Graduate Program at North Carolina State University. Together with Dr. Hodgson, he coedited the two previous editions of this book.
ERNEST HODGSON, PhD, is Distinguished Professor Emeritus of Environmental and Molecular Toxicology and Executive Director of the Foundation for Agromedicine and Toxicology at North Carolina State University. Alongside the previous editions of this book, he edited four editions ofA Textbook of Modern Toxicology (Wiley) and is the Editor of the Journal of Biochemical and Molecular Toxicology.
  • Intro
  • Title Page
  • Table of Contents
  • Preface
  • List of Contributors
  • Section 1: Introduction
  • 1 Molecular and Biochemical Toxicology
  • 1.1 Introduction
  • 1.2 Sources of Information
  • 1.3 Toxicology
  • 1.4 Molecular and Cellular Toxicology
  • 1.5 Proteomics and Metabolomics
  • 1.6 Role of Molecular, Cellular, and Biochemical Toxicology: Implications for Risk Assessment
  • 1.7 Conclusions
  • Suggested Reading
  • Section 2: Techniques in Biochemical and Molecular Toxicology
  • 2 Molecular Techniques for the Study of Gene Function
  • 2.1 Applicability of Molecular Techniques to Toxicology
  • 2.2 Overview of Genes, Chromatin, and Their Relationship
  • 2.3 Approaches to Characterize the Functions of Genes
  • 2.4 Gene Targeting Technologies
  • 2.5 Analysis of Gene Expression and Regulatory Mechanisms
  • 2.6 Methods to Evaluate Gene Function in an Animal Model
  • References
  • Suggested Reading
  • 3 Transcriptomics
  • 3.1 Introduction
  • 3.2 Cellular Organization and the Transcriptome
  • 3.3 RNA Isolation
  • 3.4 Platforms for Transcriptome Analysis: Microarrays
  • 3.5 RNA-seq: NextGen Sequencing of the Transcriptome
  • 3.6 Validation of Transcriptome Analysis
  • 3.7 Analysis of Gene Expression Data
  • 3.8 Summary
  • References
  • 4 Proteomics
  • 4.1 Introduction to Proteomics
  • 4.2 Mass Spectrometry
  • 4.3 Quantitation of Proteins by LC-MS/MS
  • 4.4 Emerging Research Areas in Proteomics
  • 4.5 Summary
  • Suggested Reading
  • 5 Metabolomics
  • 5.1 Introduction
  • 5.2 Endogenous and Exogenous Metabolites
  • 5.3 Study Design and Experimental Considerations
  • 5.4 Applications of Metabolomics
  • 5.5 Technologies for Targeted and Broad-Spectrum Metabolomics
  • 5.6 Statistical and Multivariate Analysis and Pathway Mapping
  • 5.7 Summary
  • Acknowledgment
  • References
  • 6 Cellular Techniques
  • 6.1 Introduction
  • 6.2 Cellular Studies in Intact Tissue
  • 6.3 Studies with Dispersed, Isolated Cells
  • 6.4 Monolayer Cell Culture
  • 6.5 Observation of Cultured Cells
  • 6.6 Indicators of Toxicity
  • 6.7 Important Considerations and Advances
  • 6.8 Replacement of Animal Testing with Cell Culture Models
  • 6.9 Conclusion
  • Suggested Reading
  • Journals
  • 7 Basic Concepts of Molecular Epidemiological Research Methods
  • 7.1 Introduction
  • 7.2 Molecular Epidemiology
  • 7.3 Descriptive Epidemiologic Study Designs
  • 7.4 Analytic Epidemiologic Studies
  • 7.5 Experimental Studies
  • 7.6 Inferring Causality from Molecular Epidemiologic Data
  • 7.7 Summary
  • References
  • Suggested Reading
  • Molecular Epidemiology
  • Reading Materials Related to Examples
  • Section 3: Mechanisms in Molecular and Biochemical Toxicology
  • 8 Phase I and Phase II Metabolism and Metabolic Interactions
  • 8.1 Introduction
  • 8.2 Metabolic Enzymes
  • 8.3 Phase I Reactions
  • 8.4 Phase II Reactions
  • 8.5 Reactive Metabolites
  • 8.6 Factors Affecting Metabolism
  • 8.7 Synergism and Potentiation
  • 8.8 Biphasic Effects
  • 8.9 Environmental Effects
  • 8.10 Human Variation in Toxicant Metabolism
  • 8.11 Summary of Toxicant Metabolism
  • Suggested Reading
  • 9 Structure, Mechanism, and Regulation of Cytochromes P450
  • 9.1 Introduction
  • 9.2 Complexity of the Cytochrome 450 Gene Superfamily
  • 9.3 Cytochrome P450 Structure
  • 9.4 Mechanisms of P450 Catalysis
  • 9.5 Cytochrome P450 Regulation
  • 9.6 Transgenic Animal Models
  • 9.7 Reactive Oxygen Species
  • 9.8 Posttranslational Modification of P450s
  • 9.9 Summary
  • Suggested Reading
  • 10 Polymorphisms in Phase I and Phase II Genes and Outcomes
  • 10.1 Introduction
  • 10.2 Toxicogenetics and Single Nucleotide Polymorphisms (SNPS)
  • 10.3 Polymorphic Cytochrome P450 and Xenobiotics Metabolism
  • 10.4 Other Polymorphic Phase I Genes and Xenobiotics Metabolism
  • 10.5 Polymorphisms: Mechanistic Classification
  • 10.6 Methods for the Study of Polymorphisms
  • 10.7 Phase II Gene Polymorphisms and Xenobiotics Metabolism
  • 10.8 Regulation of Phase II Genes Via Antioxidant Responsive Element
  • Suggested Reading
  • 11 Cellular Transport and Elimination
  • 11.1 Transport as a Determinant of Xenobiotic Action
  • 11.2 Factors Affecting Membrane/Tissue Permeability
  • 11.3 Xenobiotic Transporters
  • 11.4 Altered Xenobiotic Transport
  • Suggested Reading
  • 12 Nuclear Receptors
  • 12.1 Introduction
  • 12.2 NR Structure Function
  • 12.3 Nomenclature
  • 12.4 NR Transactivation
  • 12.5 NRS in Toxicology
  • 12.6 Endobiotic and Xenobiotic Metabolism
  • 12.7 Defining New NR Targets for Toxicity: Toxcast and Tox21
  • Reference
  • Suggested Reading
  • 13 Mechanisms of Cell Death
  • 13.1 Introduction
  • 13.2 How Cells/Tissues React to "Stress"
  • 13.3 Cell Injury and Cell Death
  • 13.4 Morphology of Cell Injury and Cell Death
  • 13.5 Apoptosis, Morphology, and Mechanisms
  • 13.6 Other Cell Death Modalities
  • Acknowledgments
  • Reference
  • Suggested Reading
  • 14 Mitochondrial Dysfunction
  • 14.1 Introduction
  • 14.2 Mitochondrial Function
  • 14.3 Mitochondrial Apoptosis/Necrosis
  • 14.4 Toxicant-Induced Mitochondrial Apoptosis/Necrosis
  • References
  • 15 Reactive Metabolites, Reactive Oxygen Species (ROS), and Toxicity
  • 15.1 Introduction
  • 15.2 Enzymes Involved in Bioactivation
  • 15.3 Stability of Reactive Metabolites
  • 15.4 Factors Affecting Metabolic Balance and Toxicity
  • 15.5 Reactive Oxygen Species (ROS) and Toxicity
  • Suggested Reading
  • 16 DNA Damage and Mutagenesis
  • 16.1 Introduction
  • 16.2 Endogenous DNA Damage
  • 16.3 Environmental DNA Damage
  • 16.4 Concepts of Mutagenesis
  • 16.5 Mechanisms of DNA Damage-Induced Mutagenesis
  • Suggested Reading
  • 17 DNA Repair
  • 17.1 Introduction
  • 17.2 Direct Reversal of Base Damage
  • 17.3 Base Excision Repair
  • 17.4 Nucleotide Excision Repair
  • 17.5 Mismatch Repair
  • 17.6 Recombinational Repair
  • 17.7 DNA Repair and Chromatin Structure
  • 17.8 DNA Repair in Mitochondria
  • 17.9 DNA Repair and Cancer
  • 17.10 Summary
  • Reference
  • Suggested Reading
  • 18 Carcinogenesis
  • 18.1 Introduction
  • 18.2 Human Cancer
  • 18.3 Categorization of Agents Associated with Carcinogenesis
  • 18.4 Somatic Mutation Theory
  • 18.5 Epigenetic Mechanism of Tumorigenesis
  • 18.6 Multistage Tumorigenesis
  • 18.7 Oncogenes
  • 18.8 Tumor Suppressor Genes
  • 18.9 Mutator Phenotype/DNA Stability Genes
  • 18.10 Conclusions
  • Reference
  • Suggested Reading
  • Section 4: Molecular and Biochemical Aspects of Organ Toxicology
  • 19 Molecular Mechanisms of Respiratory Toxicity
  • 19.1 Introduction
  • 19.2 Anatomy and Function of the Respiratory Tract
  • 19.3 Toxicant-Induced Lung Injury, Remodeling, and Repair
  • 19.4 Occupational and Environmental Lung Diseases
  • Suggested Reading
  • 20 Molecular Mechanisms of Hepatotoxicity
  • 20.1 Introduction
  • 20.2 Liver Organization and Cellular Components
  • 20.3 Acute and Chronic Hepatotoxicity
  • 20.4 Types of Hepatotoxicity
  • 20.5 Mechanisms of Hepatotoxicity
  • 20.6 Autoprotection and Protective Priming
  • 20.7 Experimental Prediction of Hepatotoxicity
  • 20.8 Compounds Causing Liver Injury
  • 20.9 Conclusions
  • Suggested Reading
  • 21 Molecular Mechanisms of Renal Toxicology
  • 21.1 Introduction
  • 21.2 Influence of Renal Structure and Function on Susceptibility to Nephrotoxicity and Renal Damage
  • 21.3 Classification of Renal Injury
  • 21.4 Assessment of Renal Function in the Clinic and in Animal Models
  • 21.5 General Considerations for Choosing an Experimental Model to Study Nephrotoxicity
  • 21.6 In Vitro Models to Study Mechanisms of Renal Injury
  • 21.7 General Considerations Regarding Responses to Toxicants at the Cellular Level
  • 21.8 Mechanisms of Toxicant Action in the Kidneys
  • 21.9 Human Disease and Risk Assessment in Renal Toxicology
  • 21.10 Summary
  • References
  • 22 Molecular Mechanisms of Neurotoxicity
  • 22.1 Introduction
  • 22.2 Neurotransmission
  • 22.3 Inter- and Intracellular Signaling
  • 22.4 Excitotoxicity
  • 22.5 Protein Modifications
  • 22.6 Neuroinflammation
  • 22.7 Epigenetics
  • 22.8 Concluding Remarks
  • Suggested Reading
  • 23 Molecular Mechanisms of Immunotoxicity
  • 23.1 Introduction and Overview of the Immune System
  • 23.2 Immune Hypersensitivities and Autoimmune Disease
  • 23.3 Mucosal Immunity, the Microbiome, and Food Allergies
  • 23.4 Molecular Immunotoxicology of Environmental Stressors
  • 23.5 Methods for Assessing Immunotoxicology
  • 23.6 Summary
  • References
  • 24 Molecular Mechanisms of Reproductive Toxicity
  • 24.1 Introduction
  • 24.2 Organization of the Reproductive System: Sexual Differentiation
  • 24.3 Neuroendocrine Regulation of Reproduction
  • 24.4 Female Reproductive System
  • 24.5 Toxicity in the Male Reproductive System
  • 24.6 Transgenerational Effects on Reproduction
  • 24.7 Summary
  • References
  • 25 Molecular Mechanisms of Developmental Toxicity
  • 25.1 Introduction
  • 25.2 Overview of Development and General Principles
  • 25.3 Wilson's Principles of Teratology
  • 25.4 Selected Examples of Developmental Toxicants
  • 25.5 Advances in Developmental Toxicology Methods
  • 25.6 Summary
  • References
  • Section 5: Emerging Areas in Molecular and Biochemical Toxicology
  • 26 Computational and Molecular Approaches to Risk Assessment
  • 26.1 Introduction
  • 26.2 High-Throughput Bioactivity
  • 26.3 High-Throughput Toxicokinetics
  • 26.4 High-Throughput Exposure
  • 26.5 Summary
  • References
  • 27 Nanotoxicology
  • 27.1 Introduction
  • 27.2 Naturally Occurring and Unintentional Nanoparticles
  • 27.3 Engineered Nanomaterials
  • 27.4 Exposure to Nanoparticles
  • 27.5 Protein Corona Formation on Nanoparticles
  • 27.6 Nanoparticle Interactions with Biological Barriers
  • 27.7 Degradation and Clearance
  • 27.8 Adverse Effects of Nanoparticles
  • 27.9 Nanomedicine
  • 27.10 Life Cycle of Nanoparticles in the Environment
  • Suggested Reading
  • 28 Developmental Origins of Health and Disease
  • 28.1 Introduction
  • 28.2 Historical Perspective: Birth Weight and Early Life Nutrition in Adult Health
  • 28.3 The Effects of Environmental Chemicals on the Programming of Adult Health
  • 28.4 Biological Mechanisms
  • 28.5 Conclusions
  • Suggested Reading
  • 29 Exposome
  • 29.1 Introduction
  • 29.2 The Exposome and Disease Pathways
  • 29.3 The Blood Exposome
  • 29.4 The Exposome and Social Factors
  • 29.5 Discovering Causes of Disease
  • 29.6 The Future of the Exposome
  • Acknowledgments
  • References
  • Index
  • End User License Agreement

Molecular and Biochemical Toxicology: Definition and Scope

Ernest Hodgson1 and Robert C. Smart2

1 Center for Human Health and the Environment, Department of Applied Ecology and Toxicology Program, North Carolina State University, Raleigh, NC, USA

2 Center for Human Health and the Environment, Toxicology Program, and Department of Biological Sciences, North Carolina State University, Raleigh, NC, USA

1.1 Introduction

Since the previous edition, toxicology has seen a dramatic increase in the application of the principles and methods of molecular approaches, particularly as it relates to targeted and unbiased approaches in transcriptomics, epigenomics, proteomics, and metabolomics. Biochemical and molecular toxicology is concerned with the definition, at the molecular and cellular levels, of the cascade of events that is initiated by exposure to a toxicant and culminates in the expression of a toxic endpoint. Molecular techniques have provided a wealth of mechanistic information about the role of gene function in the interaction of xenobiotics and living organisms. The development of knockout and knockin mice, as well as "humanized mice" with human genes inserted into their genome, and collaborative cross mice with genetic diversity similar to human populations has proven extremely valuable in investigations of toxicant metabolism, modes of toxic action, and gene-by-environment (GxE) interactions. Diverse models including zebrafish, C. elegans, yeast, Drosophila, and Daphnia, among others, also provide important models to study the molecular mechanisms of how environmental toxicants promote disease and induce toxic effects. The field is making rapid and significant progress in understanding the complex molecular and biochemical mechanisms through which environmental stressors interface with pathways, the genome, and the epigenome to influence toxicity and health outcomes, and these advances are reflected in this edition, the fifth. From the biomolecule, pathway, cell, tissue, organ, model organism, and human-to-human population, the new edition integrates these levels of biological organization.

Toxicology can be defined as the branch of science dealing with poisons. Having said that, attempts to define all of the various parameters lead to difficulties. The first difficulty is seen in the definition of a poison. Broadly speaking, a poison is any substance causing harmful effects in an organism to which it is administered, either deliberately or by accident. Clearly, this effect is dose related inasmuch as any substance, at a low enough dose, is without effect, while many, if not most, substances have deleterious effects at some higher dose. Much of toxicology deals with compounds exogenous to the normal metabolism of the organism, such compounds being referred to as xenobiotics. However, many endogenous compounds, including metabolic intermediates such as glutamate or hormones such as thyroxine, are toxic when administered in unnaturally high doses. Similarly, trace nutrients such as selenium, which are essential in the diet at low concentrations, are frequently toxic at higher levels. The production of reactive oxygen species (ROS) and subsequent events is a frequent sequel to interaction with xenobiotics that has significant consequences in terms of cell toxicity and health outcomes.

The expression of toxicity and the assessment of toxic effects are other parameters of considerable complexity. Acute toxicity, usually measured as mortality and expressed as the lethal dose or concentration required to kill 50% of an exposed population under defined conditions (LD50 or LC50), is probably the simplest measure of toxicity. Nevertheless, it varies with age, gender, diet, the physiological condition of the animals, environmental conditions, and the method of administration. Chronic toxicity may be manifested in a variety of ways, including cancer, cataracts, peptic ulcers, and reproductive effects, to name only a few. Furthermore, chemicals may have different effects at different doses. For example, vinyl chloride is a potent hepatotoxicant at high doses and a carcinogen with a very long latent period at low doses. Considerable variation also exists in the toxic effects of the same chemical administered to different animal species or even to the same animal when administered via different routes. Malathion, for example, has relatively low toxicity to mammals but is toxic enough to insects to be a widely used commercial insecticide.

Additionally, there are critical windows of susceptibility to certain toxicants; for example, exposures to certain toxicant or dietary conditions during development can influence later susceptibility to certain adult diseases. As described in "Developmental Origins of Health and Disease" (Chapter 28), exposures to certain toxicants or dietary conditions during development can modify the epigenome, and these modifications are important determinants of certain adult diseases/adverse health outcomes.

1.2 Sources of Information

In keeping with the textbook format, the most important sources of information are appended to all 29 chapters as "Suggested Reading" for the user. Taken together they form an in-depth source of extended information on all aspects of molecular and biochemical toxicology and serve to promote further understanding. Having individual chapter "Suggested Reading" lists rather than a consolidated list is more user friendly and, more important, facilitates a more focused exploration of specific topics. The current fifth edition consists of 29 chapters and is divided into 5 areas following each other in logical sequence. They are:

  1. Introduction
  2. Techniques in Molecular and Biochemical Toxicology
  3. Mechanisms in Molecular and Biochemical Toxicology
  4. Molecular and Biochemical Aspects of Organ Toxicity
  5. Emerging Areas in Molecular and Biochemical Toxicology

1.3 Toxicology

Toxicology is clearly related to two of the applied biologies: medicine and agriculture. In medicine, clinical diagnosis and treatment of poisoning as well as the management of toxic side effects of clinical drugs are areas of significance. In agriculture, the development of selective biocides such as insecticides, herbicides, and fungicides is important, and their nontarget effects are of considerable public health significance. Toxicology may also be considered an area of fundamental science because the adaptation of organisms to toxic environments has important implications for ecology and evolution. Toxicology is a critical part of environmental health science and occupational safety and is important in understanding individual and population susceptibility.

The tools of chemistry, biochemistry, and molecular biology are the primary tools of toxicology, and progress in toxicology is closely linked to the development of new methodology in these sciences. Those of chemistry provide analytical methods for toxicants and their metabolites, particularly for forensic toxicology, residue analysis, and toxicant metabolism as well as for proteomic and metabolomics to measure changes in proteins or metabolites, respectively, such as biomarkers of exposure or disease or related to the mechanism of toxicity. Methodologies of biochemistry are employed for the investigation of metabolism and modes of toxic action and those of molecular biology for investigations of the roles of genes and gene expression in toxicity and GxE interactions.

Molecular and biochemical toxicology deals with processes that occur at the cellular and molecular levels when toxic chemicals interact with living organisms. Defining these interactions is fundamental to our understanding of toxic effects, both acute and chronic, and is essential for the development of new therapies, for the determination of environmental occupational toxic hazards, and for the development of new clinical drugs for medicine and biocides for agriculture.

The poisoning process may be thought of as a cascade of more or less distinct events. While biochemical and molecular toxicology is involved in all of these, their involvement in exposure analysis is restricted to the discovery and use of biomarkers of exposure. Following exposure, uptake involves the biochemistry of cell membranes and distribution or transport processes within the body (see Chapter 11). Metabolism, which may take place at portals of entry or, following distribution, in other organs, particularly the liver, may either detoxify toxicants or activate them to reactive metabolites more toxic than the parent chemical (see Chapter 8, "Phase I and Phase II Metabolism and Metabolic Interactions: A Summary"). Polymorphisms in genes that metabolize xenobiotics have important toxicological consequences as described in "Polymorphisms in Phase I and Phase II Genes and Outcomes" (Chapter 10). Chemicals with intrinsic toxicity or reactive metabolites are involved in various modes of toxic action, usually initiated by interactions with macromolecules such as proteins and DNA. Chapters on DNA damage and mutagenesis (Chapter 16), DNA repair (Chapter 17), and carcinogenesis (Chapter 18) focus on the outcomes of the interactions of these reactive metabolites or ROS with DNA. ROS produced by endogenous or exogenous molecules are important in toxicity and have been implicated in numerous human diseases. How damaged cells make decisions to live or die is described in "Mechanisms of...

Dateiformat: EPUB
Kopierschutz: Adobe-DRM (Digital Rights Management)


Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat EPUB ist sehr gut für Romane und Sachbücher geeignet - also für "fließenden" Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Weitere Informationen finden Sie in unserer E-Book Hilfe.

Download (sofort verfügbar)

134,99 €
inkl. 19% MwSt.
Download / Einzel-Lizenz
ePUB mit Adobe DRM
siehe Systemvoraussetzungen
E-Book bestellen

Unsere Web-Seiten verwenden Cookies. Mit der Nutzung dieser Web-Seiten erklären Sie sich damit einverstanden. Mehr Informationen finden Sie in unserem Datenschutzhinweis. Ok